Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anjum B Khan

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Ejhaem|July 14, 2026
A Delphi Consensus on Optimising the Care Pathway for Adult Patients With Acute Myeloid Leukaemia (AML): Strategies to Enhance Transplant Accessibility and Feasibility in the United KingdomPriyanka Mehta, Francesca A M Kinsella, Thomas P Coats, et al.
BMJ Open|January 8, 2025
Intestinal <i>M</i>icrobiota Transplant Prior to <i>A</i>llogeneic <i>S</i>tem Cell <i>T</i>ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
British Journal of Haematology|July 8, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UKPriyanka Mehta, Victoria Campbell, Jamie Maddox, et al.
The Journal of Clinical Investigation|February 28, 2018
Redirection to the bone marrow improves T cell persistence and antitumor functionsAnjum B Khan, Ben Carpenter, Pedro Santos E Sousa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Ejhaem|July 14, 2026
A Delphi Consensus on Optimising the Care Pathway for Adult Patients With Acute Myeloid Leukaemia (AML): Strategies to Enhance Transplant Accessibility and Feasibility in the United KingdomPriyanka Mehta, Francesca A M Kinsella, Thomas P Coats, et al.
BMJ Open|January 8, 2025
Intestinal <i>M</i>icrobiota Transplant Prior to <i>A</i>llogeneic <i>S</i>tem Cell <i>T</i>ransplant (MAST) trial: study protocol for a multicentre, double-blinded, placebo-controlled, phase IIa trialBenjamin H Mullish, Andrew J Innes, Lauren A Roberts, et al.
British Journal of Haematology|July 8, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UKPriyanka Mehta, Victoria Campbell, Jamie Maddox, et al.
The Journal of Clinical Investigation|February 28, 2018
Redirection to the bone marrow improves T cell persistence and antitumor functionsAnjum B Khan, Ben Carpenter, Pedro Santos E Sousa, et al.
Pageof 1